Analysis category

Harm Reduction & Unknown Sample Screening

Screening and contamination analysis to help characterise unknown or unidentified samples where the contents are not declared.

At a glance

Sample type

Powder, tablet, capsule, oil or solution

Quantity required

Approximately 50 mg, 2 units or 2 ml

Turnaround

7–12 working days from receipt

Methods used

GC-MS, LC-MS, HPLC

Unknown-sample screening is exploratory rather than targeted. We report what our methods detect; a compound outside the scope of those methods will not be identified, and no screen can rule out every possible substance.

What these analyses are designed to assess

  • Broad screening to identify the principal components present
  • Detection of contaminants and unexpected substances
  • Indicative relative proportions where determinable
  • A written summary of what was and was not detected

Catalogue

Available analyses

Pricing shown in USD. The listed price is the full price for that analysis — no hidden fees.

Optional add-ons

Available alongside any analysis in this category.

Ready to order this analysis?

Place your order and we will send you sample submission and shipping instructions, along with the reference to include with your sample.

Analytical information only. Puralytix provides independent laboratory analysis and informational reports. We do not sell compounds of any kind, and we do not provide medical, dosing, sourcing, legal or consumption advice. A result does not imply that a substance is safe, approved, lawful or suitable for human use. Clients are responsible for complying with the laws of their own jurisdiction.